Current Status of Primary Cytoreductive Surgery for the Treatment of Advanced Epithelial Ovarian Cancer

E-ISSN： 1875-6301|5|1|67-79

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.5, Iss.1, 2009-02, pp. : 67-79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complete Cytoreductive Surgery Is Feasible and Maximizes Survival in Patients with Advanced Epithelial Ovarian Cancer: A Prospective Study

By Eisenkop S.M. Friedman R.L. Wang H.-J.

Gynecologic Oncology, Vol. 69, Iss. 2, 1998-05 ,pp. : 103-108

Elsevier

Access to resources Recommend Favorite

Cytoreductive Surgery for Ovarian Cancer

By Omura G.A.

Gynecologic Oncology, Vol. 80, Iss. 2, 2001-02 ,pp. : 332-332

Elsevier

Access to resources Recommend Favorite

Secondary Cytoreductive Surgery for Localized Intra-abdominal Recurrences in Epithelial Ovarian Cancer

By Munkarah A. Levenback C. Wolf J.K. Bodurka-Bevers D. Tortolero-Luna G. Morris R.T. Gershenson D.M.

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 237-241

Elsevier

Access to resources Recommend Favorite

Antiangiogenic Drugs in the Treatment of Advanced Epithelial Ovarian Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 8, 2012-10 ,pp. : 982-987

Bentham Science Publishers

Access to resources Recommend Favorite

Optimal Cytoreductive Surgery Is an Independent Prognostic Indicator in Stage IV Epithelial Ovarian Cancer with Hepatic Metastases

By Naik R. Nordin A. Cross P.A. Hemming D. de Barros Lopes A. Monaghan J.M.

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 171-175

Elsevier

Access to resources Recommend Favorite